Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
12/2010
12/30/2010US20100330106 Method of Treating Cancer with DLL4 Antagonist and Chemotherapeutic Agent
12/30/2010US20100330105 Anticancer Combination Therapies
12/30/2010US20100330104 Methods of using btl-ii proteins
12/30/2010US20100330103 Antibodies Directed to Alpha V Beta 6 And Uses Thereof
12/30/2010US20100330102 Immunoglobulin preparation for the treatment of hiv-1 infection
12/30/2010US20100330101 BIFUNCTIONAL CpG OR OLIGO-/POLYNUCLEOTIDE AND TOXIN OR ENTEROTOXIN CONTAINING COMPOSITION
12/30/2010US20100330100 Pseudomonas aeruginosa-outer membrane protein pa4710
12/30/2010US20100330099 Stabilized anti-hepatitis b (hbv) antibody formulations
12/30/2010US20100330098 Methods to regulate glucose metabolism
12/30/2010US20100330097 Predicting amd with snps within or near c2, factor b, plekha1, htra1, prelp, or loc387715
12/30/2010US20100330096 Methods of treating diseases with anti-vegf antibodies
12/30/2010US20100330095 Axl antibodies
12/30/2010US20100330094 Anti-IP-10 Antibodies and Methods of Use Thereof
12/30/2010US20100330093 Treatment of melanoma with alpha thymosin peptides in combination with antibodies against cytotoxic t lymphocyte-associated antigen 4 (ctla4)
12/30/2010US20100330092 Monoclonal antibody having neutralizing activity against mmp13
12/30/2010US20100330091 Immunoreactive glycoprotein gp19 ehrlichia canis
12/30/2010US20100330090 Antagonist antibodies of protease activated receptor-1 (par1)
12/30/2010US20100330089 Anti-cd20 therapeutic compositions and methods
12/30/2010US20100330088 Strategies to prevent and/or treat immunie responses to soluble allofactors
12/30/2010US20100330087 Methods for treating cancer using combination therapy
12/30/2010US20100330086 Cationic steroid antimicrobial compositions and methods of use
12/30/2010US20100330085 Method of treatment, prophylaxis and diagnosis of pathologies of the bone
12/30/2010US20100330084 Single domain vhh antibodies against von willebrand factor
12/30/2010US20100330083 Plasminogen activator variant formulations
12/30/2010US20100330082 Nlrr-1 antagonists and uses thereof
12/30/2010US20100330081 Cripto binding molecules
12/30/2010US20100330080 Antigen binding polypeptides
12/30/2010US20100330079 Biomarkder combinations for colorectal cancer
12/30/2010US20100330078 Alpha 5 - beta 1 antibodies and their uses
12/30/2010US20100330077 1-acetic acid-indole derivatives with pgd2 antagonist activity
12/30/2010US20100330076 Immunoglobulin fc polypeptides
12/30/2010US20100330075 Monoclonal human tumor-specific antibody
12/30/2010US20100330074 Use of saccharides cross-reactive with bacillus anthracis spore glycoprotein as a vaccine against anthrax
12/30/2010US20100330073 Methods of treatment using antibodies to neutrokine-alpha
12/30/2010US20100330072 Myostatin binding agents
12/30/2010US20100330071 Method to produce a highly concentrated immunoglobulin preparation for subcutaneous use
12/30/2010US20100330070 Methods Of Making An Antibody And Compositions Thereof
12/30/2010US20100330069 Heterocyclic compounds and methods of use
12/30/2010US20100330068 Monomeric vhh domain derived from anti-vp6 camelid antibodies, dimeric domain, immunisation method, rotavirus detection method, composition, prevention and treatment methods for rotavirus infections
12/30/2010US20100330067 Compounds and Methods for the Modulation of Toll-Like Receptor Function
12/30/2010US20100330066 Methods for Use with Baff Antagonists
12/30/2010US20100330034 Use of bispecific antibodies to regulate immune responses
12/30/2010US20100330030 Vasculostatic Agents and Methods of Use Thereof
12/30/2010US20100329987 Uses of Sperm Membrane Protein OBF
12/30/2010US20100329983 Compounds and methods for the detection of trpv-6 cancers and drug delivery
12/30/2010US20100329982 Particles with inducible change of shape
12/30/2010US20100329981 Simplified and improved method for preparing an antibody or an antibody fragment targeted immunoliposome for systemic administration of a therapeutic or diagnostic agent
12/30/2010US20100329980 Humanized anti-alpha 9 integrin antibodies and the uses thereof
12/30/2010US20100329976 Nanoparticulate compositions of angiogenesis inhibitors
12/29/2010WO2010151840A2 Albumin-free botulinum toxin formulations
12/29/2010WO2010151770A1 Method of treating cancer with dll4 antagonist and chemotherapeutic agent
12/29/2010WO2010151675A1 Active cores of peptide triazole hiv-1 entry inhibitors
12/29/2010WO2010151673A1 Swine influenza hemagglutinin variants
12/29/2010WO2010151544A1 Immunogenic compositions of staphylococcus aureus antigens
12/29/2010WO2010151526A1 Bispecific antibodies that bind to complement proteins
12/29/2010WO2010151348A1 Treatment of pervasive developmental disorders with tocotrienols or tocotrienol enriched extracts
12/29/2010WO2010151341A1 Method for treating chronic lymphocytic leukemia
12/29/2010WO2010151159A2 Virus-like particle vector as a polyvalent platform for intracellular delivery of high-molecular-weight therapeutic substances, method for generating a virus like particle vector and use of a virus-like particle vector and a pharmaceutical composition containing said virus-like particle vector
12/29/2010WO2010151076A2 Adjuvant composition comprising (poly-gamma-glutamate)-chitosan nanoparticles
12/29/2010WO2010150982A2 Recombinant hemagglutinin protein having superior biocompatibility for an influenza virus vaccine, and method for preparing biodegradable plga microspheres containing same
12/29/2010WO2010150819A1 Therapeutic agent for ischemic cerebrovascular disorders
12/29/2010WO2010150242A2 Immunogenic streptococcus pneumoniae peptides and peptide-multimers
12/29/2010WO2010149963A1 Cancer vaccine
12/29/2010WO2010149752A2 Novel compositions
12/29/2010WO2010149745A1 Recombinant rsv antigens
12/29/2010WO2010149743A2 Vaccine
12/29/2010WO2010148541A1 A immunogenic composition comprising peptides derived from cytomegalovirus and the use thereof
12/29/2010WO2010148511A1 Chimeric influenza virus-like particles comprising hemagglutinin
12/29/2010WO2010148496A1 Lipidated tumor- associated antigens and immunotherapeutic compositions
12/29/2010WO2010148434A1 Chimeric molecules
12/29/2010WO2010148422A1 Compounds and methods for treating parasitic infestations
12/29/2010WO2010130898A3 Menigococcus vaccine containing lipooligosaccharide (los) from modified strains of l6 immunotype neisseria meningitidis
12/29/2010WO2010127420A9 Genetically modified sequences encoding plasmodium vivax antigens
12/29/2010WO2010109324A9 Combinations of meningococcal factor h binding protein and pneumococcal saccharide conjugates
12/29/2010EP2267454A2 Diagnosis and prevention of cancer cell invasion
12/29/2010EP2267452A1 A soluble complex comprising a retroviral surface glycoprotein
12/29/2010EP2267450A2 Antibodies against histone modifications for clinical diagnosis and prognosis of cancer
12/29/2010EP2267431A2 Gas sensor
12/29/2010EP2267158A2 Identification of surface-associated Antigenes used for the diagnosis and therapy of tumours
12/29/2010EP2267157A2 Identification of surface-associated antigenes used for the diagnosis and therapy of tumours
12/29/2010EP2267156A2 Identification of surface-associated Antigenes used for the diagnosis and therapy of tumours
12/29/2010EP2267132A2 Polyepitopic protein fragments of HPV proteins E6 and E7, method for obtaining same and uses thereof, in particular for vaccination
12/29/2010EP2267125A1 Cancer cell motility and cancer cell infiltration inhibitor
12/29/2010EP2267113A1 Culture medium for Neisseria meningitidis with soy bean extract as amino acid source and no protein complexes of animal origin
12/29/2010EP2267036A1 Hypo- and Hyper-Acetylated Meningococcal Capsular Saccharides
12/29/2010EP2267035A2 Measuring Degree of Polymerisation for Meningococcal Capsular Saccharides that Contain Sialic Acid
12/29/2010EP2267032A2 Method of administering therapeutic polypeptides, and polypeptides therefor
12/29/2010EP2267031A1 Endothelial cell specific antibodies and uses thereof
12/29/2010EP2267030A1 Devices, compositions and methods for the protection and repair of cells and tissues
12/29/2010EP2267029A2 Methods and compositions for treatment of inflammatory disease using Cadherin-11 modulating agents
12/29/2010EP2267028A2 DUAL SPECIFIC SINGLE DOMAIN ANTIBODIES (dAb) conjugated to PEG
12/29/2010EP2267027A2 Method of administering therapeutic polypeptides, and polypeptides therefor
12/29/2010EP2267026A1 Albumin fusion proteins
12/29/2010EP2267023A2 KDR peptides and vaccines comprising the same
12/29/2010EP2267022A2 KDR peptides and vaccines comprising the same
12/29/2010EP2267021A2 KDR peptides and vaccines comprising the same
12/29/2010EP2267014A2 Identification of tumour-associated cell surface antigens for diagnosis and therapy
12/29/2010EP2267013A2 Identification of tumour-associated cell surface antigens for diagnosis and therapy
12/29/2010EP2267012A2 Identification of tumour-associated cell surface antigens for diagnosis and therapy
12/29/2010EP2267011A2 Identification of tumour-associated cell surface antigens for diagnosis and therapy
1 ... 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 ... 1823